Health authorities have initiated a vaccination campaign focused on approximately one million teenagers and young adults in response to rising concerns about meningitis B infections. The programme aims to protect those deemed at elevated immediate risk, particularly young people about to enter university or residential further education settings during the autumn term.
Meningitis is an infection affecting the protective membranes surrounding the brain and spinal cord. While it can develop in any age group, it occurs most frequently in babies, young children, teenagers, and young adults. The condition requires prompt medical intervention, as delayed treatment can result in serious complications. The infection may originate from bacterial or viral sources, which can be identified through diagnostic testing. Bacterial forms of meningitis are less common than viral variants but carry greater severity, potentially leading to blood poisoning, sepsis, or brain damage. Meningitis B represents the predominant cause of severe meningococcal disease within the UK, with 378 cases of invasive meningococcal disease reported in the 2024-2025 period.
Symptoms of meningitis typically emerge suddenly and may include high fever, severe headaches, neck stiffness, vomiting, diarrhoea, muscle and joint pain, light sensitivity, cold extremities, seizures, confusion, and extreme drowsiness. A characteristic rash that does not disappear when pressed with a glass is also a recognized indicator.
The MenB vaccine protects against meningococcal group B bacteria and is currently administered to infants at eight weeks, twelve weeks, and one year of age. The vaccine contains no live bacteria and cannot cause meningitis. Additional vaccines addressing other meningitis-related causes are also available through routine immunisation programmes. Authorities note that while the MenB vaccine provides protection, research indicates it does not necessarily prevent person-to-person transmission, does not cover all bacterial strains, and does not offer extended long-term protection.
Transmission occurs primarily through close personal contact, particularly via respiratory droplets from coughs, sneezes, and kissing, or through shared food and drink items. The bacteria can be carried asymptomatically in the nose and throat. Disease clusters occasionally emerge in settings with concentrated populations, such as university campuses. Urgent medical attention is recommended for anyone experiencing meningitis or sepsis symptoms.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI